ClinicalTrials.gg
RecruitingNCT06276400Updated May 4, 2026

LPFC Organization in Emotion-Duration Difference Estimation

An interventional study of Emotion valence and Time in Healthy, sponsored by University of California, Santa Barbara. Recruiting at 1 site in United States. Open to participants aged 18 Years to 45 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-05-04.

Sponsored by University of California, Santa Barbara · Not applicable, Interventional, and Basic science

From the registry’s dates

  • Started Jan 2024; still recruiting 2 years 9 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
50
Allocation
Not applicable
Ages
18 Years to 45 Years
Sex
All
01

Study summary

To support optimal behavior in daily life, goals and responses following emotional events should ideally incorporate not only the valence and intensity of prior emotional episodes but also their temporal features, such as the relative duration of positive vs. negative attributes. However, how specific brain regions contribute to the integration of temporal and emotional information and promote goal-directed response remains unknown.

The goal of this study is to examine how specific brain regions track both emotional and temporal information of dynamic emotional events to inform other related brain regions to guide goal-oriented and context-appropriate actions. The investigators will scan healthy human participants using functional MRI (fMRI) while they view emotional image sequences and track the associated emotional and temporal (duration) information, and act accordingly. The investigators will employ multivariate patterns analysis and pattern similarity analysis to identify brain regions that represent (can decode) emotion, time, and their combined signals, as well as brain regions that represent the associated action goal. In addition, to infer the causal contributions of these brain regions in forming task-relevant representations (emotion, time, and action goal), the same participants will be recruited to receive transcranial magnetic stimulation (TMS) in these regions.

Read the detailed description

Overview. n=50 participants from the UC Santa Barbara and the larger Santa Barbara community will be recruited and invited to participate in a multi-session fMRI/TMS+fMRI study. Eligibility criteria have been described and include fMRI and TMS safety criteria.

Behavioral Task. To test the hypothesis that the lateral frontal pole (FPl) represents emotion and temporal signals and integrates them to inform contextual action goal representations in the mid-lateral prefrontal cortex (mid-LPFC), the investigators will use a well-validated task that manipulates time and emotional valence factors to inform context-dependent action goals, the Emotional Sequences Task. In each trial, participants view 12-s sequences of 4 novel negative and positive images (events). Half the trials feature longer-lasting negative (vs. positive) picture presentations, and vice versa, yielding greater temporal evidence for either positive or negative emotional valence. The amount of temporal evidence in favor of one valence in a 12-s sequence (∆ Temporal evidence: 1200ms vs 1800ms) is varied orthogonally with respect to the predominant emotional valence by varying individual picture presentation times (2000ms-4000ms; jittered). At the end of each sequence, participants indicate whether the total duration of positive or negative events was longer with a button press (Left vs. Right), following an action-mapping rule (Contextual Goal Cue).

Procedure. fMRI acquisition. Using a 64-channel coil in the 3T Prisma Siemens MRI scanner located at UCSB's Brain Imaging Center (BIC), the investigators will collect whole-brain EPIs (multiband factor=3; 2.5 mm3 isotropic voxels; TR=1.5 s; TE=30 ms; FA=65°) and T1-weighted images for spatial normalization and TMS neuronavigation (0.94 mm3; TR=2.5 s; TE=2.19 ms; FA=7°). fMRI data processing and modeling. Following our prior work (see(2)), fMRI data processing, in FSL and Python, will include motion and slice time correction, 3mm FWHM smoothing, and alignment to T1-space maintaining native functional resolution. Trial-wise BOLD activation parameters for emotional sequence and action preparation epochs will be obtained using a canonical HRF in a Least-Squares All (LS-A)(3) GLM, and regularized using multivariate noise normalization(4) to remove nuisance inter-voxel correlations due to physiological and/or instrument noise. Regions of Interest (ROIs). PFC-LPFC: FPl and mid-LPFC (BA46 \& 9-46); mPFC: BA25 and BA32-Oxford PFC consensus atlas(5-7) and surface-based segmentation in Freesurfer(8) aligned to individual T1 space. Amygdala ROIs-CITI atlas(9) and ANTs registration to T1 space. fMRI analysis: Overview. Aims 1-1b: the investigators will model the following factors: predominant emotional valence (positive vs. negative; hereafter, emotion), # temporal evidence (1200ms vs. 1800ms; hereafter, time), and action goals (rule-based left vs. right; hereafter, action). MVPA. To replicate our prior work(2), which showed linear decoding of emotional valence in FPl, and action goals in FPl and mid-LPFC, the investigators will use a multivariate logistic classifier run on z-scored data for each subject, ROI, and task epoch (emotional sequences and action preparation) in Nilearn. Classifier performance will be evaluated using the area under the curve (AUC; chance performance = 0.5) and leave-one-run-out cross validation (yielding run-wise classifier AUCs). Mixed Models: Overview. Here and throughout, the investigators use mixed models (lme4(10)) entering subject and run as random factors. Classifier Mixed Models. Classifier AUC is tested against chance using mixed models combining run-wise classifier AUCs across subjects. Representational Similarity Analysis (RSA). Full-factorial RSA tests whether the inter-trial similarity structure of multivoxel neural activity patterns (i.e., the neural similarity matrix) is explained by experimental factors-here, emotional valence, time, action goals, and, critically, their interaction(2). The investigators will obtain neural similarity matrices for each participant, ROI, and task epoch by computing Pearson correlations between pairs of trial-wise multivoxel patterns in a between-runs correlation approach, which minimizes inflated correlations due to data dependencies and autocorrelation. RSA Mixed Models. Next, the investigators will fit a multiple regression mixed model for each ROI using condition-specific template matrices (each template matrix is included in the subject error term). The investigators will fit emotion, time, and emotion*time regressors (emotional-sequences epoch). This model tests whether time and emotion significantly explain the similarity structure of FPl and mid-LPFC neural activity patterns, and, critically, whether they interact (i.e., in conjunctive representations(11,12)). To test whether mid-LPFC and FPl represent action goals, the investigators will fit an action goal regressor (action preparation epoch); a secondary model will include emotion and time as interactive regressors (emotion*action, time*action, emotion*time*action) to examine whether action goal representations are unaltered by valence in mid-LPFC (vs. FPl) (as the investigators previously found(2)) or whether these factors are integrated in mid-LPFC in this task. The behavioral relevance of time, emotion, and goal signals in LPFC. The investigators will test the predicted behavioral import of integrated time-emotion signals in FPl by regressing the fit of emotion*time regressors in FPl (RSA betas) on accuracy in the Emotional Sequences Task. FPl-mid-LPFC interactions: Functional connectivity and cross-regional representational evidence. The investigators will test whether FPl's integrated time-emotion signals may inform mid-LPFC function by regressing (a) FPl's emotion*time fits (RSA betas) and (b) FPl-mid-LPFC's functional connectivity (PPI betas) on mid-LPFC's action-goal signals (AUC). Statistical Rigor. Here and throughout, all p values are FDR-adjusted to correct for multiple comparisons. Regional and representational specificity in LPFC is formally tested by entering region (FPl vs. mid-LPFC) as an interactive regressor in above-described mixed models.

The investigators will bring participants from Experiment 1.1 (Aim 1) for 3 TMS+fMRI sessions targeting FPl, mid-LPFC, and a non-PFC Control (S1) (order counterbalanced across subjects). Each TMS administration will be followed by fMRI scanning of the Emotional Sequences Task. Experiment 1.2 tests a causal role of FPl function in (a) informing action-goal representations in mid-LPFC and (b) task performance (requiring accurate tracking of temporally-extended emotional information); compared to Experiment 1.3, which targets action-goal signals in mid-LPFC, and Experiment 1.4, which targets a non-PFC control (S1).

Procedure. Information-guided TMS. Following others'(13) and our(1) recent work, individualized LPFC TMS sites will target the peak location of task-relevant classifier evidence- emotional valence in FPl, and action goals in mid-LPFC-as revealed by a spherical searchlight (7.5mm radius) run on fMRI data obtained at baseline (Experiment 1.1; Aim 1) constrained by relevant anatomical ROIs (see ROIs, Aim 1). S1 targets are defined based on anatomy(14-17). TMS sites will be a-priori restricted to the Left hemisphere given more consistent engagement of Left vs. Right LPFC during cognitive control(18-20) and emotion regulation(15,21). TMS protocol. TMS will be delivered using a Magstim Horizon Lite magnetic stimulator and a figure-of-eight coil. Precise TMS targeting is achieved using T1-weighted scans and computerized stereotaxic system (Brainsight). As in our prior work, the investigators will use an offline cTBS protocol (50Hz trains of 3 pulses every 200ms; 40 s; Huang et al. 2005), which reduces cortical activity for up to 60 min after stimulation. Questionnaires. The investigators will assess mood pre and post TMS using the PANAS(22) and STAI(23). fMRI analysis. The investigators will conduct MVPA and RSA (detailed in Aim 1). Statistical Rigor. See Aim 1; here, TMS site specificity is tested by entering TMS site (FPl vs. mid-LPFC vs. Control/S1) as an interactive factor in above-described mixed models (classifier AUC and RSA); all p-values FDR corrected for multiple comparisons.

02

Conditions studied

  • Healthy

Keywords

  • Emotion-time information integration in healthy participants
  • Neural representation of emotional events and goal action
03

In context

Lead sponsor

University of California, Santa Barbara is the lead sponsor of 14 studies on the registry; 6 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 45 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • right-handed
  • between the ages of 18 and 45
  • be a fluent English speaker
  • have normal to corrected-to-normal vision.

Exclusion criteria

Exclusion Criteria:

  • if they report a current or prior diagnosis of a psychiatric disorder requiring hospitalization and/or are currently using psychiatric medication; o If they report a history of or current neurological disease (i.e., stroke, concussion, epilepsy, major head trauma, complicated migraine);
  • If they ever had a seizure;
  • If they have a family history of epilepsy or seizure disorders;
  • If they have a history of fainting;
  • If they are sleep deprived (TMS only);
  • If they have a history of prior surgery with metal clips, implants, devices, prosthetics, cardiac or neural implants (e.g., pacemaker; neurostimulator), or cochlear implants;
  • If they are unable to safely and comfortably complete an MRI: have metal in the body, recent surgery, presence of surgically implanted devices not cleared for MRI, extreme claustrophobia, if they report tattoos of the head or neck region, non-removable metal piercing anywhere on the body
  • Women will be asked to self-report their pregnancy status and have the option to take a pregnancy test if they wish. If there is a chance a participant is pregnant, they will not be scanned.
  • As part of the newly adopted UCSB BIC prescreening procedure, participants will be asked about their history of hearing issues (including loss, hyperacuity, sensitivity to loud noises, history of tinnitus (ringing in ears), job with high noise exposure, and chronic migraines. Participants will be excluded if one or more hearing issues are reported.
05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
50 participants (estimated)

Study arms

  • Experimental
    Duration difference estimation

    Participants will view emotional sequences composed of four emotional images. They will be asked to indicate whether the total duration of positive or negative emotional events was longer, by responding with a button press to a contextual cue defining the relevant action (Left vs Right button). The amount of temporal evidence in favor of one valence in a 12-s sequence is varied orthogonally with respect to the (predominant) emotional valence by varying individual picture presentation times. Participants will undergo one fMRI session and 3 TMS+fMRI sessions (2 of the TMS sessions target prefrontal (PFC) sites, and 1 targets a non-PFC control site).

    Other: Emotion valence · Other: Time · Device: TMS Stimulation

Interventions

  • OtherEmotion valence

    Positive vs. Negative (temporally extended sequence)

  • OtherTime

    ∆ Temporal evidence (i.e. relative time difference of stimulus-type exposure across a sequence: 1200 vs. 1800)

  • DeviceTMS Stimulation

    FPl vs. mid-LPFC vs. non-PFC Control (S1); Specific LPFC region (vs. non-PFC active Control) function is manipulated with an inhibitory TMS protocol (cTBS).

06

What researchers measure

Primary outcomes

  1. Multivariate BOLD metrics

    The investigators will use BOLD activation patterns measured from each ROI to fit quantitative models of emotional valence, time, and action goal encoding. These models will be used to classify stimulus representations on experimental trials to quantify how stimulus representations are encoded in each brain region studies, and how these representations change across experimental manipulations. These measurements will be used to test the impact of stimulus manipulations on stimulus representations in different brain regions.

    Time frame: Through study completion, an average of 12-14 months

  2. Behavioral response

    On all trials participants will be instructed to attend carefully to report which valence of emotional images shown for a longer duration by pressing one of two buttons held in their hand inside the scanner. The correct button to be pressed is determined by the valence, the presentation duration, and the color of a triangle (the contextual cue). Investigators will ensure participants are performing the task as instructed by providing practices and assessing the accuracy of their behavioral responses.

    Time frame: Through study completion, an average of 12-14 months

07

Study locations

1 of 1 sites recruiting
08

References and documents

Publications

  • Lapate RC, Heckner MK, Phan A, Tambini A, D'Esposito M. Representation-based TMS to prefrontal cortex changes action goals and avoidance behavior during negative emotional processing. under review
  • Lapate RC, Ballard IC, Heckner MK, D'Esposito M. Emotional Context Sculpts Action Goal Representations in the Lateral Frontal Pole. J Neurosci. 2022 Feb 23;42(8):1529-1541. doi: 10.1523/JNEUROSCI.1522-21.2021. Epub 2021 Dec 30. PubMed 34969868 ↗
  • Mumford JA, Turner BO, Ashby FG, Poldrack RA. Deconvolving BOLD activation in event-related designs for multivoxel pattern classification analyses. Neuroimage. 2012 Feb 1;59(3):2636-43. doi: 10.1016/j.neuroimage.2011.08.076. Epub 2011 Sep 5. PubMed 21924359 ↗
  • Walther A, Nili H, Ejaz N, Alink A, Kriegeskorte N, Diedrichsen J. Reliability of dissimilarity measures for multi-voxel pattern analysis. Neuroimage. 2016 Aug 15;137:188-200. doi: 10.1016/j.neuroimage.2015.12.012. Epub 2015 Dec 18. PubMed 26707889 ↗
  • Neubert FX, Mars RB, Thomas AG, Sallet J, Rushworth MF. Comparison of human ventral frontal cortex areas for cognitive control and language with areas in monkey frontal cortex. Neuron. 2014 Feb 5;81(3):700-13. doi: 10.1016/j.neuron.2013.11.012. Epub 2014 Jan 28. PubMed 24485097 ↗
  • Sallet J, Mars RB, Noonan MP, Neubert FX, Jbabdi S, O'Reilly JX, Filippini N, Thomas AG, Rushworth MF. The organization of dorsal frontal cortex in humans and macaques. J Neurosci. 2013 Jul 24;33(30):12255-74. doi: 10.1523/JNEUROSCI.5108-12.2013. PubMed 23884933 ↗
  • Verhagen L. Prefrontal Consensus Atlas (Oxford) [Internet]. 2018. Available from: http://lennartverhagen.com/; lennart.verhagen@donders.ru.nl
  • Reuter M, Schmansky NJ, Rosas HD, Fischl B. Within-subject template estimation for unbiased longitudinal image analysis. Neuroimage. 2012 Jul 16;61(4):1402-18. doi: 10.1016/j.neuroimage.2012.02.084. Epub 2012 Mar 10. PubMed 22430496 ↗
  • Tyszka JM, Pauli WM. In vivo delineation of subdivisions of the human amygdaloid complex in a high-resolution group template. Hum Brain Mapp. 2016 Nov;37(11):3979-3998. doi: 10.1002/hbm.23289. PubMed 27354150 ↗
  • Bates D, Mächler M, Bolker B, Walker S. Fitting Linear Mixed-Effects Models Using lme4. Journal of Statistical Software, Articles. 2015;67(1):1-48.
  • Badre D, Bhandari A, Keglovits H, Kikumoto A. The dimensionality of neural representations for control. Curr Opin Behav Sci. 2021 Apr;38:20-28. doi: 10.1016/j.cobeha.2020.07.002. Epub 2020 Aug 19. PubMed 32864401 ↗
  • Freund MC, Etzel JA, Braver TS. Neural Coding of Cognitive Control: The Representational Similarity Analysis Approach. Trends Cogn Sci. 2021 Jul;25(7):622-638. doi: 10.1016/j.tics.2021.03.011. Epub 2021 Apr 21. PubMed 33895065 ↗
  • Rose NS, LaRocque JJ, Riggall AC, Gosseries O, Starrett MJ, Meyering EE, Postle BR. Reactivation of latent working memories with transcranial magnetic stimulation. Science. 2016 Dec 2;354(6316):1136-1139. doi: 10.1126/science.aah7011. PubMed 27934762 ↗
  • Lapate RC, Samaha J, Rokers B, Postle BR, Davidson RJ. Perceptual metacognition of human faces is causally supported by function of the lateral prefrontal cortex. Commun Biol. 2020 Jul 9;3(1):360. doi: 10.1038/s42003-020-1049-3. PubMed 32647260 ↗
  • Lapate RC, Samaha J, Rokers B, Hamzah H, Postle BR, Davidson RJ. Inhibition of Lateral Prefrontal Cortex Produces Emotionally Biased First Impressions: A Transcranial Magnetic Stimulation and Electroencephalography Study. Psychol Sci. 2017 Jul;28(7):942-953. doi: 10.1177/0956797617699837. Epub 2017 Jun 14. PubMed 28613974 ↗
  • Tambini A, D'Esposito M. Causal Contribution of Awake Post-encoding Processes to Episodic Memory Consolidation. Curr Biol. 2020 Sep 21;30(18):3533-3543.e7. doi: 10.1016/j.cub.2020.06.063. Epub 2020 Jul 30. PubMed 32735812 ↗
  • Tambini A, Nee DE, D'Esposito M. Hippocampal-targeted Theta-burst Stimulation Enhances Associative Memory Formation. J Cogn Neurosci. 2018 Oct;30(10):1452-1472. doi: 10.1162/jocn_a_01300. Epub 2018 Jun 19. PubMed 29916791 ↗
  • Nee DE, D'Esposito M. The hierarchical organization of the lateral prefrontal cortex. Elife. 2016 Mar 21;5:e12112. doi: 10.7554/eLife.12112. PubMed 26999822 ↗
  • Nee DE. Integrative frontal-parietal dynamics supporting cognitive control. Elife. 2021 Mar 2;10:e57244. doi: 10.7554/eLife.57244. PubMed 33650966 ↗
  • Lowe CJ, Manocchio F, Safati AB, Hall PA. The effects of theta burst stimulation (TBS) targeting the prefrontal cortex on executive functioning: A systematic review and meta-analysis. Neuropsychologia. 2018 Mar;111:344-359. doi: 10.1016/j.neuropsychologia.2018.02.004. Epub 2018 Feb 10. PubMed 29438672 ↗
  • Lapate RC, Rokers B, Tromp DP, Orfali NS, Oler JA, Doran ST, Adluru N, Alexander AL, Davidson RJ. Awareness of Emotional Stimuli Determines the Behavioral Consequences of Amygdala Activation and Amygdala-Prefrontal Connectivity. Sci Rep. 2016 May 16;6:25826. doi: 10.1038/srep25826. PubMed 27181344 ↗
  • Watson D, Clark LA, Tellegen A. Development and validation of brief measures of positive and negative affect: the PANAS scales. J Pers Soc Psychol. 1988 Jun;54(6):1063-70. doi: 10.1037//0022-3514.54.6.1063. PubMed 3397865 ↗
  • Spielberger CD, Sydeman SJ, Owen AE, Marsh BJ. Measuring anxiety and anger with the State-Trait Anxiety Inventory (STAI) and the State-Trait Anger Expression Inventory (STAXI). The use of psychological testing for treatment planning and outcomes assessment, 2nd ed. 1507;2(1999):993-1021.

Individual participant data

Plan to share: Yes — Deanonymized raw fMRI and raw behavioral data will be shared with researchers immediately upon publication.

Supporting information: Study protocol, Statistical analysis plan, Informed consent form, Analytic code

Time frame: Data will be available indefinitely beginning with the publication of results

Access criteria: Raw fMRI data and raw behavioral data will be available on the NIMH Data Archive (NDA) by submitting Data Access Requests. Experimental scripts and analysis code will be available on GitHub (an online tool for storing and managing code).

Data sharing details ↗ · github.com

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 4, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06276400
Lead sponsor
University of California, Santa Barbara
Responsible party
Regina Lapate (Assistant Professor, University of California, Santa Barbara) — Principal investigator
First posted
Feb 26, 2024
Start date
Jan 29, 2024
Primary completion
Mar 31, 2028 (estimated)
Completion
Mar 31, 2028 (estimated)
Last update
May 4, 2026

Study contacts

Mengsi Li, M.S.
Contact
mengsi.li@ucsb.edu
805-837-5206
Regina Lapate, Ph.D.
principal investigator · University of California, Santa Barbara

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion